From: Computed tomography scan based prediction of the vulnerable carotid plaque
IPH-containing (n = 37) | Non IPH-containing (n = 16) | P- value | |
---|---|---|---|
Age, y, mean (SD) | 70.19 (± 9,58) | 70.13 (± 7.32) | .816 |
Sex: | |||
- Male, % (n) | 67.6 (25) | 31.2 (5) | <.0001 |
- Female, % (n) | 32.4 (12) | 68.8 (11) | <.0001 |
Medical History: | |||
- Hypertension, % (n) | 56.8 (21) | 81.3 (13) | .091 |
- Diabetes mellitus, % (n) | 10.8 (4) | 37.5 (6) | .024 |
- Aortic valve disease, % (n) | 2.7 (1) | 0 (0) | .511 |
- Aortic valve operated, % (n) | 0 (0) | 0 (0) | 1.00 |
- Atrial fibrillation, % (n) | 10.8 (4) | 6.3 (1) | .605 |
- Smoking, % (n) | 37.8 (14) | 56.3 (9) | .219 |
- Interval (ds)a, mean (SD) | 17.92 (± 9.57) | 22.38 (± 20.15) | .869 |
Medication use: | |||
- Statins, % (n) | 43.2 (16) | 62.5 (10) | .202 |
- Vitamin K antagonists, % (n) | 8.1 (3) | 0 (0) | .245 |
- Antiplatelet agents, % (n) | 32.4 (12) | 62.5 (10) | .043 |
- Antihypertensiva, % (n) | 51.4 (19) | 81.3 (13) | .043 |
Symptomatic carotid artery | |||
- Left, % (n) | 37.8 (14) | 50.0 (8) | <.0001 |
- Right, % (n) | 62.2 (23) | 50.0 (8) | <.0001 |
Neurologic symptomatology: | |||
- TIA, % (n) | 59.5 (22) | 37.5 (6) | <.0001 |
- Stroke, % (n) | 27.8 (10) | 50.0 (8) | <.0001 |
- Amourasis Fugax, % (n) | 13.5 (5) | 12.5 (2) | .571 |